Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart Weston

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Journal of Virology|August 21, 2020
Broad Anti-coronavirus Activity of Food and Drug Administration-Approved Drugs against SARS-CoV-2 <i>In Vitro</i> and SARS-CoV <i>In Vivo</i>Stuart Weston, Christopher M Coleman, Robert Haupt, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 8, 2014
Heat shock protein 90 controls HIV-1 reactivation from latencyIan Anderson, Jun Siong Low, Stuart Weston, et al.
Life Science Alliance|May 1, 2020
Correction: Bat IFITM3 restriction depends on S-palmitoylation and a polymorphic site within the CD225 domainCamilla To Benfield, Farrell MacKenzie, Markus Ritzefeld, et al.
Life Science Alliance|December 13, 2019
Bat IFITM3 restriction depends on S-palmitoylation and a polymorphic site within the CD225 domainCamilla To Benfield, Farrell MacKenzie, Markus Ritzefeld, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 13, 2020
The SKI complex is a broad-spectrum, host-directed antiviral drug target for coronaviruses, influenza, and filovirusesStuart Weston, Lauren Baracco, Chloe Keller, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 26, 2022
Exhaled Breath Aerosol Shedding of Highly Transmissible Versus Prior Severe Acute Respiratory Syndrome Coronavirus 2 VariantsJianyu Lai, Kristen K Coleman, S H Sheldon Tai, et al.
Biorxiv : the Preprint Server for Biology|June 30, 2021
Pyrimidine biosynthesis inhibitors synergize with nucleoside analogs to block SARS-CoV-2 infectionDavid C Schultz, Robert M Johnson, Kasirajan Ayyanathan, et al.
Communications Biology|August 12, 2022
PIKfyve-specific inhibitors restrict replication of multiple coronaviruses in vitro but not in a murine model of COVID-19James Logue, Arup R Chakraborty, Robert Johnson, et al.
Nature|February 7, 2022
Pyrimidine inhibitors synergize with nucleoside analogues to block SARS-CoV-2David C Schultz, Robert M Johnson, Kasirajan Ayyanathan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 14, 2021
Infectious Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Exhaled Aerosols and Efficacy of Masks During Early Mild InfectionOluwasanmi O Adenaiye, Jianyu Lai, P Jacob Bueno de Mesquita, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Journal of Virology|August 21, 2020
Broad Anti-coronavirus Activity of Food and Drug Administration-Approved Drugs against SARS-CoV-2 <i>In Vitro</i> and SARS-CoV <i>In Vivo</i>Stuart Weston, Christopher M Coleman, Robert Haupt, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 8, 2014
Heat shock protein 90 controls HIV-1 reactivation from latencyIan Anderson, Jun Siong Low, Stuart Weston, et al.
Life Science Alliance|May 1, 2020
Correction: Bat IFITM3 restriction depends on S-palmitoylation and a polymorphic site within the CD225 domainCamilla To Benfield, Farrell MacKenzie, Markus Ritzefeld, et al.
Life Science Alliance|December 13, 2019
Bat IFITM3 restriction depends on S-palmitoylation and a polymorphic site within the CD225 domainCamilla To Benfield, Farrell MacKenzie, Markus Ritzefeld, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 13, 2020
The SKI complex is a broad-spectrum, host-directed antiviral drug target for coronaviruses, influenza, and filovirusesStuart Weston, Lauren Baracco, Chloe Keller, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 26, 2022
Exhaled Breath Aerosol Shedding of Highly Transmissible Versus Prior Severe Acute Respiratory Syndrome Coronavirus 2 VariantsJianyu Lai, Kristen K Coleman, S H Sheldon Tai, et al.
Biorxiv : the Preprint Server for Biology|June 30, 2021
Pyrimidine biosynthesis inhibitors synergize with nucleoside analogs to block SARS-CoV-2 infectionDavid C Schultz, Robert M Johnson, Kasirajan Ayyanathan, et al.
Communications Biology|August 12, 2022
PIKfyve-specific inhibitors restrict replication of multiple coronaviruses in vitro but not in a murine model of COVID-19James Logue, Arup R Chakraborty, Robert Johnson, et al.
Nature|February 7, 2022
Pyrimidine inhibitors synergize with nucleoside analogues to block SARS-CoV-2David C Schultz, Robert M Johnson, Kasirajan Ayyanathan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 14, 2021
Infectious Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Exhaled Aerosols and Efficacy of Masks During Early Mild InfectionOluwasanmi O Adenaiye, Jianyu Lai, P Jacob Bueno de Mesquita, et al.
Pageof 4